INS and Hepatic steatosis: Accumulating studies have demonstrated that the plasma levels of FGF21 increase in parallel with the severity of hepatic steatosis in humans [176,178], and are positively associated with TG, fasting insulin, and other insulin resistance indices, while negatively correlated with body mass index and HDL [179,180].